Edition:
United States

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

123.00EUR
11:35am EDT
Change (% chg)

€-1.90 (-1.52%)
Prev Close
€124.90
Open
€124.25
Day's High
€124.40
Day's Low
€122.35
Volume
12,416
Avg. Vol
7,142
52-wk High
€177.30
52-wk Low
€122.35

Chart for

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 1.03
Market Cap(Mil.): €1,056.40
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.66 16.34
EPS (TTM): -- -- --
ROI: -- 15.09 14.66
ROE: -- 16.32 14.00

Virbac cuts full-year revenue forecast amid still weak US sales

Sept 11 French veterinary pharmaceutical firm Virbac cut its full-year outlook on Monday, saying it now expected revenue to be little changed from last year after a fall in U.S. sales affected its first-half earnings.

Sep 11 2017

BRIEF-Virbac H1 net profit group share rises to 13.9 ‍million euros

* H1 NET PROFIT GROUP SHARE EUR 13.9 ‍​MILLION VERSUS EUR 13.1 MILLION YEAR AGO

Sep 11 2017

BRIEF-Creso Pharma signs commercialisation agreement with Virbac

* Signed a commercialisation agreement with Virbac, for the launch of its hemp‐based complementary animal feed products Source text for Eikon: Further company coverage:

Aug 06 2017

BRIEF-Virbac Q‍2 consolidated revenue up to 234.8 million euros

* ‍CONSOLIDATED REVENUE IN Q2 AMOUNTED TO EUR 234.8 MILLION, UP SHARPLY BY +7.5% COMPARED TO SAME PERIOD IN 2016​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jul 17 2017

BRIEF-Virbac says Sébastien Huron to become new Chairman

* REG-VIRBAC : SÉBASTIEN HURON WILL BECOME THE NEW CHAIRMAN OF THE EXECUTIVE BOARD AS OF DECEMBER 2017

Jun 23 2017

BRIEF-Virbac signs a research agreement with Bio-Gene

* VIRBAC SA - VIRBAC SIGNS A RESEARCH AGREEMENT WITH BIO-GENE Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Jun 16 2017

BRIEF-Biocorp signs an industrialization contract with Virbac

* INDUSTRIALIZATION CONTRACT TOTALING €1 MILLION FOR THE MANUFACTURING OF AN INNOVATIVE ADMINISTRATION AND CLOSURE SYSTEM COMPATIBLE WITH VIALS

May 29 2017

BRIEF-Virbac Q1 sales fall to 199.7 million euros

* First quarter 2017 sales down, strongly impacted by stock effects in the distribution

Apr 12 2017

Earnings vs. Estimates